These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
368 related articles for article (PubMed ID: 21356346)
1. Role of hyaluronan-mediated CD44 signaling in head and neck squamous cell carcinoma progression and chemoresistance. Wang SJ; Bourguignon LY Am J Pathol; 2011 Mar; 178(3):956-63. PubMed ID: 21356346 [TBL] [Abstract][Full Text] [Related]
2. Hyaluronan-CD44 interaction with leukemia-associated RhoGEF and epidermal growth factor receptor promotes Rho/Ras co-activation, phospholipase C epsilon-Ca2+ signaling, and cytoskeleton modification in head and neck squamous cell carcinoma cells. Bourguignon LY; Gilad E; Brightman A; Diedrich F; Singleton P J Biol Chem; 2006 May; 281(20):14026-40. PubMed ID: 16565089 [TBL] [Abstract][Full Text] [Related]
3. Activation of Matrix Hyaluronan-Mediated CD44 Signaling, Epigenetic Regulation and Chemoresistance in Head and Neck Cancer Stem Cells. Bourguignon LYW; Earle C; Shiina M Int J Mol Sci; 2017 Aug; 18(9):. PubMed ID: 28837080 [TBL] [Abstract][Full Text] [Related]
4. Stem cell marker (Nanog) and Stat-3 signaling promote MicroRNA-21 expression and chemoresistance in hyaluronan/CD44-activated head and neck squamous cell carcinoma cells. Bourguignon LY; Earle C; Wong G; Spevak CC; Krueger K Oncogene; 2012 Jan; 31(2):149-60. PubMed ID: 21685938 [TBL] [Abstract][Full Text] [Related]
5. Hyaluronan and the interaction between CD44 and epidermal growth factor receptor in oncogenic signaling and chemotherapy resistance in head and neck cancer. Wang SJ; Bourguignon LY Arch Otolaryngol Head Neck Surg; 2006 Jul; 132(7):771-8. PubMed ID: 16847188 [TBL] [Abstract][Full Text] [Related]
7. CD44 variant isoforms in head and neck squamous cell carcinoma progression. Wang SJ; Wong G; de Heer AM; Xia W; Bourguignon LY Laryngoscope; 2009 Aug; 119(8):1518-30. PubMed ID: 19507218 [TBL] [Abstract][Full Text] [Related]
8. Role of hyaluronan synthase 2 to promote CD44-dependent oral cavity squamous cell carcinoma progression. Wang SJ; Earle C; Wong G; Bourguignon LY Head Neck; 2013 Apr; 35(4):511-20. PubMed ID: 22473523 [TBL] [Abstract][Full Text] [Related]
9. Reduction of hyaluronan-CD44-mediated growth, migration, and cisplatin resistance in head and neck cancer due to inhibition of Rho kinase and PI-3 kinase signaling. Torre C; Wang SJ; Xia W; Bourguignon LY Arch Otolaryngol Head Neck Surg; 2010 May; 136(5):493-501. PubMed ID: 20479382 [TBL] [Abstract][Full Text] [Related]
10. Hyaluronan-CD44 interaction promotes microRNA signaling and RhoGTPase activation leading to tumor progression. Bourguignon LY Small GTPases; 2012; 3(1):53-9. PubMed ID: 22714418 [TBL] [Abstract][Full Text] [Related]
11. ΔNp63-mediated regulation of hyaluronic acid metabolism and signaling supports HNSCC tumorigenesis. Compagnone M; Gatti V; Presutti D; Ruberti G; Fierro C; Markert EK; Vousden KH; Zhou H; Mauriello A; Anemone L; Bongiorno-Borbone L; Melino G; Peschiaroli A Proc Natl Acad Sci U S A; 2017 Dec; 114(50):13254-13259. PubMed ID: 29162693 [TBL] [Abstract][Full Text] [Related]
12. Cancer Cell CD44 Mediates Macrophage/Monocyte-Driven Regulation of Head and Neck Cancer Stem Cells. Gomez KE; Wu F; Keysar SB; Morton JJ; Miller B; Chimed TS; Le PN; Nieto C; Chowdhury FN; Tyagi A; Lyons TR; Young CD; Zhou H; Somerset HL; Wang XJ; Jimeno A Cancer Res; 2020 Oct; 80(19):4185-4198. PubMed ID: 32816856 [TBL] [Abstract][Full Text] [Related]
13. Up-regulation of Histone Methyltransferase, DOT1L, by Matrix Hyaluronan Promotes MicroRNA-10 Expression Leading to Tumor Cell Invasion and Chemoresistance in Cancer Stem Cells from Head and Neck Squamous Cell Carcinoma. Bourguignon LY; Wong G; Shiina M J Biol Chem; 2016 May; 291(20):10571-85. PubMed ID: 27002147 [TBL] [Abstract][Full Text] [Related]
14. CD44 as a stem cell marker in head and neck squamous cell carcinoma. Faber A; Barth C; Hörmann K; Kassner S; Schultz JD; Sommer U; Stern-Straeter J; Thorn C; Goessler UR Oncol Rep; 2011 Aug; 26(2):321-6. PubMed ID: 21617876 [TBL] [Abstract][Full Text] [Related]
15. Cucurbitacin I suppressed stem-like property and enhanced radiation-induced apoptosis in head and neck squamous carcinoma--derived CD44(+)ALDH1(+) cells. Chen YW; Chen KH; Huang PI; Chen YC; Chiou GY; Lo WL; Tseng LM; Hsu HS; Chang KW; Chiou SH Mol Cancer Ther; 2010 Nov; 9(11):2879-92. PubMed ID: 21062915 [TBL] [Abstract][Full Text] [Related]
16. Targeting HIF-1α/NOTCH1 pathway eliminates CD44 Byun JY; Huang K; Lee JS; Huang W; Hu L; Zheng X; Tang X; Li F; Jo DG; Song X; Huang C Oncogene; 2022 Feb; 41(9):1352-1363. PubMed ID: 35013621 [TBL] [Abstract][Full Text] [Related]
17. The influence of hyaluronan-CD44 interaction on topoisomerase II activity and etoposide cytotoxicity in head and neck cancer. Wang SJ; Peyrollier K; Bourguignon LY Arch Otolaryngol Head Neck Surg; 2007 Mar; 133(3):281-8. PubMed ID: 17372087 [TBL] [Abstract][Full Text] [Related]
18. Dual blockade of EGFR and c-Met abrogates redundant signaling and proliferation in head and neck carcinoma cells. Xu H; Stabile LP; Gubish CT; Gooding WE; Grandis JR; Siegfried JM Clin Cancer Res; 2011 Jul; 17(13):4425-38. PubMed ID: 21622718 [TBL] [Abstract][Full Text] [Related]
19. Association of CD44 V3-containing isoforms with tumor cell growth, migration, matrix metalloproteinase expression, and lymph node metastasis in head and neck cancer. Wang SJ; Wreesmann VB; Bourguignon LY Head Neck; 2007 Jun; 29(6):550-8. PubMed ID: 17252589 [TBL] [Abstract][Full Text] [Related]
20. Hyaluronan-CD44v3 interaction with Oct4-Sox2-Nanog promotes miR-302 expression leading to self-renewal, clonal formation, and cisplatin resistance in cancer stem cells from head and neck squamous cell carcinoma. Bourguignon LY; Wong G; Earle C; Chen L J Biol Chem; 2012 Sep; 287(39):32800-24. PubMed ID: 22847005 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]